Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Persistently low alkaline phosphatase (ALP) matters because this enzyme is what allows bone-building cells to mineralize new bone, so when levels fall too low, calcium and phosphate cannot be deposited properly, leading to soft or brittle bones, stress fractures, bone and joint pain, early tooth loss, and muscle weakness. Common drivers include hypophosphatasia (an inherited ALPL gene condition), zinc or magnesium deficiency, malnutrition or malabsorption, hypothyroidism, celiac disease, severe anemia, and drugs such as bisphosphonates, denosumab, or high-dose steroids. Typical doctor next steps are repeating the ALP test, checking vitamin B6, calcium, phosphorus, magnesium, PTH, and vitamin D, considering ALPL genetic testing, and ordering X-rays or a DEXA scan before starting any bone therapy, since some osteoporosis drugs can worsen low-ALP bone disease. There are several factors that change how urgent this is and which specialist you need, so see below to understand more.
Because low ALP can quietly weaken your skeleton for years before a fracture reveals it, and because the right workup depends on your specific symptoms, medications, and family history, it helps to organize your findings before your appointment: take a free, instant, online symptom check to see which conditions may fit your picture and what to ask your doctor next.
Last reviewed for medical accuracy: 08/18/2026
Alkaline phosphatase (ALP) is an enzyme critical for bone mineralization and overall skeletal strength. When lab tests show alkaline phosphatase low, it signals a potential disruption in bone-building processes. Understanding the causes, consequences, and next steps helps you and your healthcare provider protect long-term bone health.
Alkaline phosphatase works by:
When ALP levels fall below the normal range, bones can’t mineralize properly, leading to softening, pain, and fractures.
When alkaline phosphatase low, symptoms often relate to weak or soft bones:
Because these signs overlap with other conditions (e.g., osteoporosis, arthritis), proper testing is essential.
A targeted workup helps pinpoint the cause of low ALP and guides treatment:
Once you and your doctor identify the underlying cause, treatment focuses on restoring normal bone mineralization:
If you experience severe bone pain, sudden fractures, or new muscle weakness, prompt evaluation is essential. For less urgent concerns, you might start with a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance on possible next steps.
Low alkaline phosphatase can quietly undermine your skeletal health, but with early detection and targeted treatment, you can protect bone strength and reduce fracture risk. Remember:
Your bones matter every day. If you have questions about low alkaline phosphatase or related symptoms, don’t wait—speak to your doctor and get the answers you need to keep your skeleton strong.
(References)
* Rubinstein HM, Shah DM. Pseudogout. Semin Arthritis Rheum. 1972-1973;2(3):259-80. doi: 10.1016/0049-0172(72)90011-x. PMID: 4354552.
* FRASER D. Hypophosphatasia. Am J Med. 1957 May;22(5):730-46. doi: 10.1016/0002-9343(57)90124-9. PMID: 13410963.
* Inoue M. [Hypophosphatasia]. Nihon Rinsho. 2006 Jun 28;Suppl 2:104-7. PMID: 16817361.
* Chen H, Han Y, Li X, Liu X, Feng W, Xu W. Hypophosphatasia. Skeletal Radiol. 2013 Feb;42(2):295-6, 317-8. doi: 10.1007/s00256-012-1456-8. PMID: 22729426.
* Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013 Jun;10 Suppl 2:380-8. PMID: 23858621.
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017 Sep;122(1-2):4-17. doi: 10.1016/j.ymgme.2017.07.010. Epub 2017 Jul 25. PMID: 28888853.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Reis FS, Lazaretti-Castro M. Hypophosphatasia: from birth to adulthood. Arch Endocrinol Metab. 2023 May 25;67(5):e000626. doi: 10.20945/2359-3997000000626. PMID: 37249457; PMCID: PMC10665056.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.